CYTOMED THERAPEUTICS LTD (GDTC) Stock Balance Sheet
NASDAQ:GDTC • SGXZ17669631
Current stock price
1 USD
0 (0%)
Last:
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.85M | 4.97M | 9.00M | 1.58M | 2.51M | |||
| Receivables | 172.00K | 121.20K | 204.70K | 60.00K | 10.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.06M | 909.10K | 896.80K | 860.00K | 770.00K | |||
| Total Current Assets | 4.08M | 6.00M | 10.10M | 2.49M | 3.28M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.47M | 3.25M | 2.06M | 2.47M | 2.50M | |||
| Investments And Advances | 228.60K | 221.00K | 195.10K | 240.00K | 270.00K | |||
| Goodwill | 400.00 | 400.00 | 400.00 | 0.00 | 0.00 | |||
| Intangibles | 72.20K | 92.70K | 12.10K | 20.00K | 30.00K | |||
| Total Non-Current Assets | 4.27M | 4.07M | 2.27M | 2.74M | 2.80M | |||
| TOTAL ASSETS | 8.36M | 10.07M | 12.37M | 5.23M | 6.08M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 3.70M | 2.66M | |||
| Current Portion Of LT Debt. | 57.80K | 45.90K | 40.30K | 40.00K | 40.00K | |||
| Accrued Expenses | 264.00K | 363.70K | 446.60K | 240.00K | 150.00K | |||
| Accounts Payable | 82.70K | 38.60K | 24.60K | 10.00K | 50.00K | |||
| Other Current Liabilities | 298.50K | 158.40K | 205.40K | 170.00K | 40.00K | |||
| Total Current Liabilities | 703.10K | 606.60K | 716.90K | 4.17M | 2.94M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 431.80K | 417.30K | 407.80K | 480.00K | 550.00K | |||
| Total Non-Current Liabilities | 507.40K | 495.10K | 406.90K | 470.00K | 550.00K | |||
| TOTAL LIABILITIES | 1.21M | 1.10M | 1.12M | 4.64M | 3.49M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -16.57M | -14.77M | -12.26M | -8.20M | -5.07M | |||
| Additional Paid In Capital | N/A | N/A | N/A | 0.00 | 1.14M | |||
| Minority Interest | 75.70K | 77.80K | -1.00K | 0.00 | 0.00 | |||
| Common Shares | 23.79M | 23.79M | 23.72M | 8.91M | 6.55M | |||
| Other Shareholders' Equity | -77.20K | -53.80K | -217.40K | -130.00K | -30.00K | |||
| Shares Outstanding | 11.53M | 11.53M | 11.53M | 11.53M | 10.94M | |||
| Tangible Book Value per Share | 0.61 | 0.77 | 0.97 | 0.05 | 0.23 | |||
| Total Shareholders' Equity | 7.15M | 8.97M | 11.25M | 590.00K | 2.59M | |||
| TOTAL LIABILITIES AND EQUITY | 8.36M | 10.07M | 12.37M | 5.23M | 6.08M | |||
| Statistics | ||||||||
| Debt/Equity | 0.06 | 0.05 | 0.04 | 7.08 | 1.24 | |||
| Current Ratio | 5.81 | 9.89 | 14.08 | 0.60 | 1.12 | |||
| Return On Assets (ROA) | -43.94% | -25.00% | -33.41% | -59.85% | -33.72% | |||
| Return On Equity (ROE) | -51.38% | -28.07% | -36.75% | -530.51% | -79.15% | |||
All data in SGD , ROIC based on taxRate of 0.21